| Ms Rebecca Nicolette Verhaeghe, DO | |
|
10500 Quivira Rd, Overland Park, KS 66215-2306 | |
| (913) 310-0225 | |
| (913) 310-0565 |
| Full Name | Ms Rebecca Nicolette Verhaeghe |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 10500 Quivira Rd, Overland Park, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194068882 | NPI | - | NPPES |
| 200034427 | Medicaid | MO | |
| 201238780A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2016026401 (Missouri) | Secondary |
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 05-41899 (Kansas) | Primary |
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
GlobeImmune Inc. today announced that a late breaking abstract related to GI-5005, its investigational hepatitis C virus (HCV) product candidate, has been accepted for presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place Oct. 31 through Nov. 4, 2009, in Boston, Mass.
Cedars-Sinai researchers have successfully tested two new methods for preserving cognition in laboratory mice that exhibit features of Alzheimer's disease by using white blood cells from bone marrow and a drug for multiple sclerosis to control immune response in the brain.
The new health law will infuse $3 billion into health research that compares treatments to gauge which are most effective, building on an earlier federal investment of $1.1 billion from the stimulus package, Bloomberg BusinessWeek reports.
Plexxikon today announced publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatment of metastatic melanoma patients with the BRAF V600E mutation resulted in significant tumor shrinkage in the majority of patients. Specifically, in the melanoma extension cohort of the study, nearly all patients showed some response; 81 percent of patients had tumor shrinkage of at least 30 percent.
For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rebecca Nicolette Verhaeghe, DO 11600 College Blvd, Ste 201, Overland Park, KS 66210 Ph: (913) 310-0225 | Ms Rebecca Nicolette Verhaeghe, DO 10500 Quivira Rd, Overland Park, KS 66215-2306 Ph: (913) 310-0225 |
News Archive
GlobeImmune Inc. today announced that a late breaking abstract related to GI-5005, its investigational hepatitis C virus (HCV) product candidate, has been accepted for presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place Oct. 31 through Nov. 4, 2009, in Boston, Mass.
Cedars-Sinai researchers have successfully tested two new methods for preserving cognition in laboratory mice that exhibit features of Alzheimer's disease by using white blood cells from bone marrow and a drug for multiple sclerosis to control immune response in the brain.
The new health law will infuse $3 billion into health research that compares treatments to gauge which are most effective, building on an earlier federal investment of $1.1 billion from the stimulus package, Bloomberg BusinessWeek reports.
Plexxikon today announced publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatment of metastatic melanoma patients with the BRAF V600E mutation resulted in significant tumor shrinkage in the majority of patients. Specifically, in the melanoma extension cohort of the study, nearly all patients showed some response; 81 percent of patients had tumor shrinkage of at least 30 percent.
For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.
› Verified 4 days ago
Dr. Fred Fletcher Roberts, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5610 W 131st Ter, Overland Park, KS 66209 Phone: 913-402-9813 | |
Patricia C Bell, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5808 W 110th St, Overland Park, KS 66211 Phone: 913-696-8000 Fax: 816-302-9939 | |
Jennifer P Bernard, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 12541 Foster St, Suite 300, Overland Park, KS 66213 Phone: 913-317-3200 Fax: 913-317-3218 | |
Dr. Robert Vincent Jackson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8901 W 74th St, Suite 10, Overland Park, KS 66204 Phone: 913-362-1660 | |
Dr. Kathryn Ann Hartman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8901 W 74th St, Overland Park, KS 66204 Phone: 913-362-1660 | |
Brynn E Everist, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8675 College Blvd Ste 200, Overland Park, KS 66210 Phone: 913-491-5501 | |
Rima Mounla, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10208 W 147th St, Overland Park, KS 66221 Phone: 502-963-1031 |